Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.

Panico L, Ronconi F, Lepore M, Tenneriello V, Cantore N, Dell'Angelo AC, Ferbo U, Ferrara F.

Leuk Lymphoma. 2013 Nov;54(11):2418-25. doi: 10.3109/10428194.2013.778405. Epub 2013 Apr 11.

PMID:
23432688
2.

High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.

Panico L, Tenneriello V, Ronconi F, Lepore M, Cantore N, Dell'Angelo AC, Ferbo L, Ferrara F.

Leuk Lymphoma. 2015 Jun;56(6):1636-42. doi: 10.3109/10428194.2014.951849. Epub 2014 Nov 3.

PMID:
25098425
3.

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.

Koh YW, Park CS, Yoon DH, Suh C, Huh J.

PLoS One. 2014 Jan 29;9(1):e87066. doi: 10.1371/journal.pone.0087066. eCollection 2014.

4.

The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.

Abdou AG, Asaad NY, Loay I, Shabaan M, Badr N.

J Environ Pathol Toxicol Oncol. 2013;32(4):289-305.

PMID:
24579783
5.

The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.

Jakovic LR, Mihaljevic BS, Perunicic Jovanovic MD, Bogdanovic AD, Andjelic BM, Bumbasirevic VZ.

Leuk Lymphoma. 2011 Oct;52(10):1913-9. doi: 10.3109/10428194.2011.580026. Epub 2011 Jun 12.

PMID:
21663512
6.

The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.

Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J.

Oncologist. 2012;17(6):871-80. doi: 10.1634/theoncologist.2012-0034. Epub 2012 May 15.

7.

CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.

Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F.

Am J Clin Pathol. 2014 Mar;141(3):381-7. doi: 10.1309/AJCP61TLMXLSLJYS.

PMID:
24515766
8.

CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.

Kayal S, Mathur S, Karak AK, Kumar L, Sharma A, Bakhshi S, Raina V.

Leuk Lymphoma. 2014 May;55(5):1031-7. doi: 10.3109/10428194.2013.824079. Epub 2014 Mar 10.

PMID:
24067108
9.

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR, d'Amore F.

Haematologica. 2011 Feb;96(2):269-76. doi: 10.3324/haematol.2010.031542. Epub 2010 Nov 11.

10.

Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.

Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M, Morii E, Aozasa K.

Virchows Arch. 2011 Oct;459(4):361-6. doi: 10.1007/s00428-011-1140-8. Epub 2011 Aug 28.

PMID:
21874508
12.

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.

Deau B, Bachy E, Ribrag V, Delarue R, Rubio MT, Bosq J, Varet B, Brousse N, Hermine O, Canioni D.

Leuk Lymphoma. 2013 Jan;54(1):41-5. doi: 10.3109/10428194.2012.698274. Epub 2012 Jul 9.

PMID:
22667341
13.

CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.

Agur A, Amir G, Paltiel O, Klein M, Dann EJ, Goldschmidt H, Goldschmidt N.

Leuk Lymphoma. 2015 May;56(5):1315-9. doi: 10.3109/10428194.2014.963081. Epub 2014 Oct 9.

PMID:
25204373
14.

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.

Tan KL, Scott DW, Hong F, Kahl BS, Fisher RI, Bartlett NL, Advani RH, Buckstein R, Rimsza LM, Connors JM, Steidl C, Gordon LI, Horning SJ, Gascoyne RD.

Blood. 2012 Oct 18;120(16):3280-7. doi: 10.1182/blood-2012-04-421057. Epub 2012 Sep 4.

15.

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.

Azambuja D, Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N.

Ann Oncol. 2012 Mar;23(3):736-42. doi: 10.1093/annonc/mdr157. Epub 2011 May 20.

16.

Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.

Karube K, Niino D, Kimura Y, Ohshima K.

Pathol Res Pract. 2013 Apr;209(4):201-7. doi: 10.1016/j.prp.2012.11.003. Epub 2013 Mar 9.

PMID:
23478005
17.

Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin's lymphoma.

Jakovic LR, Mihaljevic BS, Jovanovic MD, Bogdanovic AD, Andjelic BM, Bumbasirevic VZ.

Onkologie. 2012;35(12):733-9. doi: 10.1159/000343664. Epub 2012 Nov 20.

PMID:
23207618
18.

Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma.

Tzankov A, Matter MS, Dirnhofer S.

Pathobiology. 2010;77(6):301-8. doi: 10.1159/000321567. Epub 2011 Jan 24.

PMID:
21266828
19.

Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.

Barros MH, Hassan R, Niedobitek G.

Clin Cancer Res. 2012 Jul 15;18(14):3762-71. doi: 10.1158/1078-0432.CCR-12-0129. Epub 2012 May 29.

20.

Supplemental Content

Support Center